Analystreport

Jazz Pharmaceuticals PLC (NASDAQ: JAZZ) had its "outperform" rating re-affirmed by analysts at Wells Fargo & Co. They now have a $186.00 price target on the stock, up previously from $168...

Jazz Pharmaceuticals plc - Ordinary Shares  (JAZZ) 
Last jazz pharmaceuticals plc - ordinary shares earnings: 2/25 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: jazzpharma.com